Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Depreciation and Depletion (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Depreciation and Depletion for 6 consecutive years, with $300000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion fell 25.0% to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 58.06% year-over-year, with the annual reading at $1.3 million for FY2025, 27.78% down from the prior year.
  • Depreciation and Depletion hit $300000.0 in Q4 2025 for Bolt Biotherapeutics, roughly flat from $300000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.8 million in Q1 2024 to a low of $200000.0 in Q2 2021.
  • Historically, Depreciation and Depletion has averaged $460000.0 across 5 years, with a median of $400000.0 in 2021.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 260.0% in 2024 and later crashed 77.78% in 2025.
  • Year by year, Depreciation and Depletion stood at $400000.0 in 2021, then rose by 25.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then fell by 20.0% to $400000.0 in 2024, then dropped by 25.0% to $300000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for BOLT at $300000.0 in Q4 2025, $300000.0 in Q3 2025, and $300000.0 in Q2 2025.